FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets (Q46133357)

19 December 2017

title

FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets (English)

1 reference

19 December 2017

autosomal dominant hypophosphatemic rickets

main subject

0 references

author name string

Yue Sun

1

1 reference

19 December 2017

Ou Wang

2

1 reference

19 December 2017

Weibo Xia

3

1 reference

19 December 2017

Yan Jiang

4

1 reference

19 December 2017

Mei Li

5

1 reference

19 December 2017

Xiaoping Xing

6

1 reference

19 December 2017

Yingying Hu

7

1 reference

19 December 2017

Huaicheng Liu

8

1 reference

19 December 2017

Xunwu Meng

9

1 reference

19 December 2017

Xueying Zhou

10

1 reference

19 December 2017

publication date

28 June 2011

1 reference

19 December 2017

Journal of Bone and Mineral Metabolism

published in

1 reference

19 December 2017

volume

30

1 reference

19 December 2017

page(s)

78-84

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s00774-011-0285-5

exact match

0 references

cites work

FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Hypophosphatemia: the common denominator of all rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Serum FGF23 levels in normal and disordered phosphorus homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

The assessment of phosphate reabsorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

What's new in hypophosphataemic rickets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Structural and biochemical properties of fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Bone as a source of FGF23: regulation by phosphate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Normal FGF23 levels in adult idiopathic phosphate diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-011-0285-5

Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder

21 January 2018

1 reference

12 December 2020

Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family

1 reference

12 December 2020

Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets

1 reference

12 December 2020

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement

1 reference

12 December 2020

Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia

1 reference

12 December 2020

Growth Disturbance in Hereditary Hypophosphatemia

1 reference

12 December 2020

STUDIES IN HYPOPHOSPHATEMIC VITAMIN D-REFRACTORY OSTEOMALACIA IN ADULTS

1 reference

12 December 2020

Familial hypophosphatemic rickets showing autosomal dominant inheritance

1 reference

12 December 2020

10.1007/S00774-011-0285-5

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

21710177

1 reference

19 December 2017